Straight pricing talk from Democratic contenders

There’s a consensus among the Democratic presidential candidates that policymakers ought to step in more aggressively to lower drug prices. Beyond that, however, there are subtle but meaningful differences in their viewpoints.

STAT’s Andrew Joseph sat in on the Boston Globe editorial board's interviews with seven of the candidates — including Elizabeth Warren, Amy Klobuchar, and Pete Buttigieg. He asked tough questions, such as whether the candidates might be able to accept fewer drugs being invented.

“…drug companies are profiteering at record levels,” Andrew Yang told STAT. “If they argue, hey, if our profits are less, we’re going to have less in innovation — it’s not plausible.”